BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18999987)

  • 21. Design and synthesis of benzylidenecyclohexenones as TrxR inhibitors displaying high anticancer activity and inducing ROS, apoptosis, and autophagy.
    Qian J; Xu Z; Meng C; Liu J; Hsu PL; Li Y; Zhu W; Yang Y; Morris-Natschke SL; Lee KH; Zhang Y; Ling Y
    Eur J Med Chem; 2020 Oct; 204():112610. PubMed ID: 32736231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lichen Acids May Be Used as A Potential Drug For Cancer Therapy; by Inhibiting Mitochondrial Thioredoxin Reductase Purified From Rat Lung.
    Ozgencli I; Budak H; Ciftci M; Anar M
    Anticancer Agents Med Chem; 2018; 18(11):1599-1605. PubMed ID: 29793415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase.
    Duan D; Zhang B; Yao J; Liu Y; Sun J; Ge C; Peng S; Fang J
    Free Radic Biol Med; 2014 Apr; 69():15-25. PubMed ID: 24407164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Mammalian Thioredoxin Reductase Inhibitors.
    Arnér ESJ
    Handb Exp Pharmacol; 2021; 264():289-309. PubMed ID: 32767140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
    Huang J; Xu J; Tian L; Zhong L
    Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Photoactive Platinum(IV) Anticancer Complex Inhibits Thioredoxin-Thioredoxin Reductase System Activity by Induced Oxidization of the Protein.
    Du J; Wei Y; Zhao Y; Xu F; Wang Y; Zheng W; Luo Q; Wang M; Wang F
    Inorg Chem; 2018 May; 57(9):5575-5584. PubMed ID: 29688719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anticancer effects of chaetocin are independent of programmed cell death and hypoxia, and are associated with inhibition of endothelial cell proliferation.
    Isham CR; Tibodeau JD; Bossou AR; Merchan JR; Bible KC
    Br J Cancer; 2012 Jan; 106(2):314-23. PubMed ID: 22187030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells.
    Zhang J; Li Y; Duan D; Yao J; Gao K; Fang J
    Biochem Pharmacol; 2016 Feb; 102():34-44. PubMed ID: 26686580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting thioredoxin reductase by deoxyelephantopin from Elephantopus scaber triggers cancer cell apoptosis.
    Duan D; Wang Y; Pan D; Wang L; Xiao J; Song P; Jin X; Wang X
    Arch Biochem Biophys; 2021 Oct; 711():109028. PubMed ID: 34509463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.
    Lu J; Chew EH; Holmgren A
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12288-93. PubMed ID: 17640917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents.
    Sun Y; Rigas B
    Cancer Res; 2008 Oct; 68(20):8269-77. PubMed ID: 18922898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1.
    Zhang X; Lu J; Ren X; Du Y; Zheng Y; Ioannou PV; Holmgren A
    Free Radic Biol Med; 2015 Dec; 89():192-200. PubMed ID: 26169724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions.
    Du Y; Wu Y; Cao X; Cui W; Zhang H; Tian W; Ji M; Holmgren A; Zhong L
    Biochimie; 2009 Mar; 91(3):434-44. PubMed ID: 19059456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule inhibitors of mammalian thioredoxin reductase.
    Cai W; Zhang L; Song Y; Wang B; Zhang B; Cui X; Hu G; Liu Y; Wu J; Fang J
    Free Radic Biol Med; 2012 Jan; 52(2):257-65. PubMed ID: 22064364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the potential of thioredoxin reductase inhibitors for cancer therapy.
    Urig S; Becker K
    Semin Cancer Biol; 2006 Dec; 16(6):452-65. PubMed ID: 17056271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Anticancer Activity of Auranofin.
    Onodera T; Momose I; Kawada M
    Chem Pharm Bull (Tokyo); 2019; 67(3):186-191. PubMed ID: 30827998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant.
    Zhao R; Masayasu H; Holmgren A
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8579-84. PubMed ID: 12070343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peperomin E and its orally bioavailable analog induce oxidative stress-mediated apoptosis of acute myeloid leukemia progenitor cells by targeting thioredoxin reductase.
    Wang X; Gao M; Zhang J; Ma Y; Qu W; Liang J; Wu H; Wen H
    Redox Biol; 2019 Jun; 24():101153. PubMed ID: 30909158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The thioredoxin antioxidant system.
    Lu J; Holmgren A
    Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
    Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
    Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.